Bank of New York Mellon Corp Invests $33.36 Million in Teleflex Incorporated $TFX

Key Points

• Bank of New York Mellon purchased 263,156 Teleflex shares worth approximately $33.36 million, acquiring about 0.59% of the company. Institutional investors collectively own 95.62% of Teleflex.
• Analyst sentiment is mixed, with an average rating of “Hold” and an average price target of $152.90; individual targets range from $138 to $159.
• Teleflex beat quarterly earnings expectations, reporting $1.76 in EPS versus $1.28 expected and $570.33 million in revenue, up 28.9% year over year. The company also declared a quarterly dividend of $0.34 per share, yielding about 1.0% annually.

Bank of New York Mellon Corp purchased a new position in Teleflex Incorporated (NYSE:TFX - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 263,156 shares of the medical technology company's stock, valued at approximately $33,358,000. Bank of New York Mellon Corp owned about 0.59% of Teleflex as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in TFX. Kelleher Financial Advisors purchased a new stake in Teleflex during the 2nd quarter valued at $25,000. Banque Cantonale Vaudoise raised its stake in shares of Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company's stock worth $31,000 after purchasing an additional 113 shares during the last quarter. UMB Bank n.a. lifted its holdings in shares of Teleflex by 57.1% during the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company's stock valued at $38,000 after purchasing an additional 113 shares in the last quarter. Kestra Advisory Services LLC purchased a new stake in shares of Teleflex during the fourth quarter valued at $45,000. Finally, Hantz Financial Services Inc. boosted its position in shares of Teleflex by 40.5% during the fourth quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company's stock valued at $48,000 after buying an additional 113 shares during the last quarter. Institutional investors own 95.62% of the company's stock.

Wall Street Analysts Forecast Growth

TFX has been the topic of several research analyst reports. BMO Capital Markets started coverage on Teleflex in a report on Wednesday, July 8th. They set an "outperform" rating and a $159.00 price target on the stock. Mizuho boosted their price target on Teleflex from $140.00 to $145.00 and gave the company a "neutral" rating in a research note on Wednesday, July 15th. Truist Financial increased their price objective on shares of Teleflex from $143.00 to $150.00 and gave the stock a "hold" rating in a research note on Monday, August 10th. Wells Fargo & Company raised their price objective on shares of Teleflex from $130.00 to $138.00 and gave the stock an "equal weight" rating in a report on Friday, May 8th. Finally, Raymond James Financial restated an "outperform" rating and set a $150.00 target price on shares of Teleflex in a research report on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $152.90.

Teleflex Stock Up 1.5%

Shares of NYSE TFX opened at $139.81 on Friday. The company has a current ratio of 2.60, a quick ratio of 2.12 and a debt-to-equity ratio of 0.94. Teleflex Incorporated has a 12-month low of $100.18 and a 12-month high of $145.00. The firm's 50-day moving average price is $133.86 and its 200-day moving average price is $125.91. The stock has a market capitalization of $5.92 billion, a price-to-earnings ratio of -6.00, a P/E/G ratio of 0.92 and a beta of 0.81.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 EPS for the quarter, topping the consensus estimate of $1.28 by $0.48. The company had revenue of $570.33 million during the quarter, compared to analyst estimates of $559.59 million. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.The firm's revenue was up 28.9% on a year-over-year basis. During the same quarter last year, the business posted $3.73 earnings per share. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, equities research analysts anticipate that Teleflex Incorporated will post 7.26 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, August 14th will be issued a dividend of $0.34 per share. The ex-dividend date is Friday, August 14th. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex's payout ratio is presently -5.84%.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source